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Abstract 20 
Introduction: Patients presenting with both chronic periprosthetic joint infection (PJI) 21 
and extensor mechanism disruption (EMD) pose a significant challenge. As there is little 22 
in the literature regarding outcomes of patients with concomitant PJI and EMD, we 23 
performed a multicenter study to evaluate the outcomes. 24 
Methods: Sixty patients with concomitant diagnoses of PJI and EMD were evaluated 25 
from 5 institutions. Patient demographics, presentation type, surgical management and 26 
outcomes including recurrent infections, final surgery and ambulatory status were 27 
documented.   28 
Results: Fifty-three of 60 patients had an attempted extensor mechanism 29 
reconstruction/repair (EMR) of which 12 (23%) were successful, averaging 3.5 (range 2-30 
7) intervening surgeries. Forty-one patients (77%) were considered failures  with 31 
recurrence  of infection as most common failure (80%); 26 ended in fusion, 10 in above 32 
knee amputation, 3 with chronic resection arthroplasty and 2 with chronic spacers/EMD. 33 
Seven patients had no attempt at EMR but proceeded directly to fusion (n=6) or 34 
amputation (n=1). There was no statistical difference between groups that had success or 35 
failure of EMR in age, American Society for Anesthesiologists Physical Status 36 
Classification System, or Body Mass Index.  37 
Conclusions:  Our study demonstrates that concomitant EMD and PJI is a dreaded 38 
combination with poor outcomes regardless of treatment. Eradication of infection and 39 
reconstruction of the extensor mechanism often requires numerous surgeries and despite 40 
great effort often ends in failure. Consideration of early fusion or amputation may be 41 
preferable in some patients to avoid the morbidity and mortality of repeated surgeries.  42 
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INTRODUCTION 47 
Infection following total knee arthroplasty (TKA) remains one of the most 48 
dreaded and difficult complications to treat. The overall incidence of infection in the 49 
literature ranges between 0.5% to 2% for primary TKAs and 2% to 4% for revision 50 
TKAs.[1-4] In 2005, 16.8% of all revision TKAs in the United States of America were 51 
done because of infection and it is estimated that by the year 2030, 65% of all revision 52 
procedures will be performed because of infection.[5] While successful eradication of 53 
periprosthetic joint infection (PJI) has been reported in the range of 85-95%, the mortality 54 
associated with PJI is high.[6] 55 
Disruption of the extensor mechanism is an infrequent, but catastrophic 56 
complication following TKA. Reports in the literature range from 1.4 to 3.2 percent.[7-57 
10]  Repair or reconstruction to the extensor mechanism disruption (EMD) is technically 58 
challenging. Multiple techniques have been described and inconsistent results in the 59 
literature with variable outcomes have been recorded.[11] A recent longitudinal study of 60 
patients treated with extensor mechanism reconstruction (EMR) using allograft 61 
demonstrated 69% of knees retained the allograft at a mean follow up of 68 months. 62 
However, the reoperation rate was high at 58% with the most common reason for 63 
reoperation being development of PJI at 26% .[12] 64 
Patients presenting with both chronic PJI and EMD pose a significant challenge.  65 
Both conditions are rare and the combination of the two diagnoses is even more rare.  66 
Allograft or synthetic material used for reconstruction can create difficulty for infection 67 
eradication. Removal of the extensor mechanism to treat the PJI can create substantial 68 
functional disability. While in the past these complications were often treated with fusion, 69 
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functional limitations associated with arthrodesis have led many to attempt 70 
reconstruction/re-implantation in the hopes of maintaining greater function.[13, 14] To 71 
date there is little data in the literature to guide surgeons and patients on the outcomes of 72 
patients that end up with both of these devastating complications[12]. We performed a 73 
multicenter study to evaluate the outcomes of patients that have concomitant PJI and 74 
EMD. Our purpose was to evaluate the treatment strategies used and determine the 75 
outcomes, including functional status, of patients that present with these complications. 76 
In addition, we sought to determine risk factors for failure. 77 
 78 
METHODS 79 
We performed a multi-center retrospective review of patients with concomitant 80 
diagnoses of PJI and EMD regardless of management.  A query of the 5 participating 81 
tertiary referral centers’ databases (XXX, XXX, XXX, XXX, XXX including 16  82 
surgeons) was completed to identify all patients with a diagnosis of PJI (996.66) and 83 
TKA removal (CPT 27385 and 27488) with keywords of Marlex, aortobifemoral, 84 
quad(riceps) rupture, patella(r) tendon rupture and disruption. Patients less than 18 years 85 
of age and native knees were excluded.  Patients diagnosed with PJI and EMD but who 86 
did not have an attempt at EMR but rather underwent early AKA or knee fusion were 87 
included in the study for comparison of clinical outcome based upon number of surgeries, 88 
complication rates, and ambulation status at final outcome.  These cases were not 89 
included in the “failure” rate of attempted extensor mechanism reconstruction.  90 
Patient demographic data at time of index surgery for PJI/EMD was collected 91 
retrospectively and included: age at the date of surgery, sex, body mass index (BMI), 92 
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American Society for Anesthesiologists Physical Status Classification System (ASA 93 
score).  The timing of the primary TKA, diagnosis of infection, diagnosis of EMD, 94 
infecting organism, and antibiotic resistance information was documented. Data was 95 
collected regarding the presentation of PJI in relation to the timing of the EMD. 96 
Additionally, presentation of PJI in relation to EMD was classified into the following 97 
groups for ease of analysis: Group A: EMD occurred first and then PJI subsequently; 98 
Group B: Concurrent EMD and PJI; Group C: PJI first and then EMD, thereafter. We 99 
also recorded the type of EMR (primary repair or reconstruction with augmentation with 100 
allograft, Marlex mesh, aortobifemoral endograft, etc.). If concurrent diagnoses of EMD 101 
and PJI on presentation, then we also noted surgical management such as two-stage 102 
exchange with EMR, arthrodesis, amputation, etc.  103 
We documented presentation type, surgical management (i.e., two-stage exchange 104 
with EMR, arthrodesis, amputation) and outcomes including reoperation (number of 105 
operations to final outcome), recurrent infections, and final surgery and ambulatory 106 
status. Ambulatory status was noted as yes/no; if yes (household or community) and 107 
whether walking aide was required and what type (cane, crutches, walker, none).  108 
We used the Musculoskeletal Infection Society (MSIS) diagnostic criteria [15].  109 
This criteria defines  that “PJI exists when either: There is a sinus tract communicating 110 
with the prosthesis; or a pathogen is isolated by culture from at least two separate 111 
samples obtained from the affected prosthetic joint; or three  of the following five  112 
criteria exist: 1) Elevated serum erythrocyte sedimentation rate (ESR) and serum C-113 
reactive protein (CRP) concentration, 2) Elevated synovial leukocyte count, 3) Elevated 114 
synovial neutrophil percentage (PMN 4) Isolation of a microorganism in one culture of 115 
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periprosthetic tissue or fluid, or 5) Greater than five neutrophils per high-power field in 116 
five high-power fields observed from histologic analysis of periprosthetic tissue at ×400 117 
magnification.” 118 
Diagnostic criteria for extensor mechanism disruption included evidence on 119 
clinical exam of extensor lag (> 15 degrees) against gravity or more and radiographic 120 
evidence of a displaced patellar fracture disrupting the longtitudinal patella, patella alta or 121 
patella baja. In some cases advanced imaging was utilized to diagnose EMD. 122 
Criteria for successful extensor mechanism reconstruction included clinical 123 
evidence of extensor mechanism continuity and function, which included continuously 124 
palpated tissue and an extensor mechanism lag of 15 degrees or less against gravity. 125 
Criteria for successful eradication of PJI was determined using the Delphi method 126 
described by Diaz-Ledezma[16].  The consensus definition of a successfully treated PJI 127 
is: (1) infection eradication, characterized by a healed wound without fistula, drainage, 128 
or pain, and no infection recurrence caused by the same organism strain; (2) no 129 
subsequent surgical intervention for infection after reimplantation surgery; and (3) no 130 
occurrence of PJI-related mortality (by causes such as sepsis, necrotizing 131 
fasciitis).  Chronic antibiotic suppression was used in some cases as morbidity and 132 
mortality of recurrent infection would not be tolerated by patient risk factors including 133 
age and comorbidities and surgical history. 134 
A total of 60 patients (22 men, 38 women) met the inclusion criteria. The mean 135 
age of the cohort was 66 years (range 38-83; SD 9.4).  The mean BMI was 34 (range 21-136 
49; SD 6.8). Overall, ASA score was II in 18, III in 27, IV in three patients, and missing 137 
for 12. Of the 60 patients, 31 presented with EMD first and subsequently developed PJI 138 
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(Group A), 17 patients presented with concurrent EMD and PJI (Group B), and 12 139 
patients developed PJI first and then EMD later (Group C).  Five of the 60 patients died 140 
during the course of treatment. 141 
RESULTS 142 
Seven of the sixty patients were treated with early above the knee amputation 143 
(AKA; n=1) or knee fusion (n=6) based upon comorbidities, soft tissue envelope, etc.  144 
We included these for analysis of ambulation and number of surgeries, we did not include 145 
them in analysis of failures of EMR as no attempt at reconstruction was made.  146 
An attempt at EMR was made in 53 of the 60 patients. The types of EMR are 147 
listed in Figure 1.  Overall 12 of the 53 patients (23%) had a successful reimplantation of 148 
their TKA, defined as presence of a functional and continuous extensor mechanism and 149 
no ongoing clinical evidence for PJI based on the defined criteria. The majority of those 150 
with a successful outcome (7 of 12) had prior E D and repair/reconstruction and 151 
subsequently developed PJI (Group A) treated with a two-stage exchange reconstruction. 152 
These patients underwent an average of 3.5 surgeries (range 2-7) between diagnosis and 153 
last surgery.  154 
Forty-one of fifty-three patients (77%) were considered failures and averaged five 155 
intervening surgeries (range 1-14). The primary mode of failure was recurrence of 156 
infection in 80% of patients (33/41), 8 for failed extensor mechanism reconstruction 157 
(20%).  Of the failures, 26 ended in fusion, 10 in AKA, 3 patients were left with chronic 158 
extensor mechanism deficiency and two patients had retained chronic static spacers with 159 
unresolved EMD.   160 
 161 
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Outcomes of Group A:  162 
Thirty-one patients were categorized into group A. Twenty-seven patients had 163 
either a reconstruction (23 pts) or an attempted primary repair (4 patients) of their EMD 164 
as their initial surgery and subsequently developed PJI.  Four patients had no attempt at 165 
limb salvage and went directly to AKA (3 patients) or fusion (1 patient) and were not 166 
counted towards failure analysis. 167 
Seven of twenty-seven patients (26%) had successful two-stage exchange and 168 
retention of their extensor mechanism. Of these seven patients, three remained on chronic 169 
suppression, three were not on chronic suppression and one had an unknown antibiotic 170 
status. Twenty of twenty-seven patients (74%) failed attempts at limb salvage with two-171 
stage exchange and EMR. Eleven patients ultimately underwent knee fusion, four 172 
patient’s had AKA, three had clinical failure and disruption of the EMR and remained on 173 
chronic antibiotics as treatment and two had retained chronic spacers. 174 
 175 
Outcomes of Group B: 176 
Seventeen patients were categorized into Group B, presenting with a concurrent 177 
PJI and EMD. Two patients from Group B had no attempt at limb salvage and went 178 
directly on to fusion and so were not included in failure analysis. The remaining 15 179 
patients all underwent resection arthroplasty with placement of a static antibiotic spacer. 180 
One patient was left with a chronic spacer in place with no further surgery.  181 
Seven patients had an attempt at primary repair of the EMD at resection or re-182 
implantation. None of these were deemed to have a functioning extensor mechanism.  183 
Five had a fusion, one an AKA and one was left with a chronic spacer after multiple 184 
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irrigation and debridement’s.  Seven patients had attempted EMR at the time of 185 
reimplantation with allograft or synthetic material. Three had successful retention of 186 
TKA and functional EMR (two were maintained on chronic antibiotic suppression) and 187 
four failed due to persistent infection resulting in four fusions and two AKAs.  188 
 189 
Outcomes of Group C: 190 
Twelve patients presented with a recent history of PJI and subsequent EMD. The 191 
most common mechanism was a fall resulting in disruption of the patellar tendon. Eighty 192 
percent failed due to recurrence of infection. 15% had complete failure of the extensor 193 
mechanism repair and 2 patients (5%) had perarticular fractures resulting in need for 194 
arthrodesis. The prior treatment of the PJI included eight patients that had undergone a 195 
prior two-stage exchange with reimplantation and four patients that had an irrigation and 196 
debridement with polyethylene exchange. One additional patient, not included in failure 197 
analysis, had no attempt at repair and went directly to a knee fusion. 198 
Of the 11 patients with EMD, 9 underwent EMR with either an allograft of 199 
synthetic material. Two of these EMR were successful at regaining functional extensor 200 
mechanism with minimal lag, no further infection, and required no additional surgery. 201 
Seven patients had recurrence of infection and subsequently underwent an arthrodesis (4 202 
patients) or an AKA (3 patient).  Two patients underwent a primary repair of the EMD, 203 
subsequent developed PJI, and had a resection and knee fusion. 204 
We found no statistical associations with age, ASA, BMI or presenting category 205 
(Group A, B, C) between the group of patients that had successful eradication of infection 206 
and EMR versus those that failed either treatment of infection or had a failed EMR 207 
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(Table 1).  However, the failure group appeared to have a higher rate of infection with 208 
resistant bacteria (MRSA) or polymicrobial infections.  209 
Regarding functional status at latest follow-up of the 55 living patients (5 patients 210 
died during course of treatment), 15 (27%) of the patients are non-ambulators, 13 (24%) 211 
are homebound ambulators, and 27 (49%) were community ambulators. Of the 15 non-212 
ambulators, 7 had an AKA, 6 had an arthrodesis, and 2 had an attempted EMR with 213 
chronic spacer. All of the homebound ambulators required the use of a gait aid and 18 of 214 
the 27 community ambulators required a gait aide. Only 9 of the 55 living patients in this 215 
series required no walking aide at latest followup.   216 
 217 
DISCUSSION 218 
Extensor mechanism disruption in the setting of periprosthetic joint infection is a 219 
rare but devastating combination. There is limited literature on this combination with 220 
most reports focused on the treatment of one and only addressing the other as a noted 221 
failure mechanism without details. The goal of infection management is to debride all 222 
questionable tissue and leave no foreign material.  Direct repair of EMD has poor results 223 
and the bulk of the literature supports bringing in bulk allograft or synthetic tissue to 224 
reinforce or bridge questionable native tissue. [17-19] 225 
Patellar tendon rupture after TKA).  Therefore, in the setting of concurrent PJI 226 
and EMD, it is difficult to accomplish both goals in one surgical intervention. 227 
Historically, the option that was considered best for these patients was arthrodesis as 228 
recurrence of infection was thought to be high with the use of allograft reconstruction in 229 
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the setting of prior infection.[14] The overall results and patient satisfaction with knee 230 
arthrodesis are quite poor leading some to attempt EMR.[13]   231 
The purpose of this multicenter study was to evaluate a cohort of patients that 232 
presented with PJI and EMD to evaluate the treatment strategies used and determine 233 
outcomes and functional status of patients that present with these complications. In 234 
addition, we sought to identify risk factors for success and failure. Our study found that 235 
of the 60 patients who met the inclusion criteria, over half (31 patients) presented with an 236 
EMD first and then PJI developed subsequently with attempted treatment of the EMD 237 
(Group A). This is not inconsistent with the prior literature of the ten major papers on 238 
reconstruction of EMD.[7, 8, 10, 12, 20-23] These papers report on a total of 196 patients 239 
and note that 12 were failures due to infection.  Though treatment and outcomes were not 240 
always delineated in these studies, approximately half of these failures were noted to 241 
have had prior infection that had recurred and the other half appeared to have developed a 242 
first time infection as a result of the EMD.  243 
We found that the concurrent diagnoses of infection and EMD was rather morbid; 244 
five of the 60 patients (12%) in our series died during the course of treatment.  This was 245 
also found in several of the other sizable series (approximately 10%-20%).[20] Most of 246 
the failures in the literature appeared to either be treated with AKA or fusion when noted 247 
though several patients (similar to our cohort) were treated with chronic spacer retention, 248 
antibiotic suppression and bracing.[21, 23] 249 
While we expected that infection would lower rates of successful EMR we were 250 
surprised that the success rate was as low as the 23% in our study. These patients also 251 
clearly endured much as they underwent an average of 3.5 intervening surgeries to 252 
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eradicate the infection and maintain a total knee with extensor function.  77% never did 253 
have a successful EMR but still averaged five intervening surgeries. We found no 254 
correlation between the type of surgery used to treat the infection and success or failure 255 
likely due to sample size. The majority of the successful EMR in our series outcome were 256 
from Group A (prior EMR and subsequently developed PJI) though this group was also 257 
the largest group in our series.  Success in this group was possibly due to the fact that 258 
these knees already had a function extensor mechanism at the time of two-stage exchange 259 
reconstruction and did not need augmentation of further tissue in face of infection. 260 
When comparing function in patients treated with EMR, AKA and fusion, the 261 
Knee Society Score and other outcome measures are not very valuable or equitable. 262 
However, ambulation is a barometer of both the quality of life in many patients’ eyes as 263 
well as a reflection of independent function. We found that  a third of our patients were 264 
not able to regain any meaningful ambulation while half were community ambulators, the 265 
majority of which needed some sort of walking aide.  Fusion was the final surgical 266 
outcome in the majority of our series (32 patients), which made up the majority of the 267 
patients that were able to return to community ambulation.  Only around half of the 268 
patients in this series returned to community ambulation and only half of these were able 269 
to ambulate without a walking aide. 270 
Recurrence of infection was the most common mode of failure, re-occurring in 271 
80% of attempts at joint salvage.   While we hoped to identify patient characteristics 272 
associated with failure that would direct the surgeon’s treatment towards a discussion of 273 
early fusion rather than reconstruction attempts, no such factors (age, ASA or BMI, etc.) 274 
were found statistically significant.  Instead, we found only a trend in infections with 275 
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“resistant organisms” (MRSA, pseudomonas, and polymicrobial infections) seemed more 276 
common in the patients that failed EMR.   277 
This study has both strengths and a number of limitations. A multicenter study 278 
allows us to pool together a larger group of patients with a very rare complication to 279 
assess treatment trends and outcomes that might otherwise have not be possible with very 280 
small numbers from a single institution. However, multicenter studies do involve 281 
numerous surgeons with varying techniques and different decision making processes 282 
when approaching a similar problem. In addition, there are inherent limitation with the 283 
retrospective nature of this study in addition to the variability of patient presentations and 284 
treatment outcomes. We are not able to make specific recommendations as to the optimal 285 
treatment for patients presenting with PJI and EMD. The overall treatment outcomes 286 
were poor and this study design allows us identify the overarching problem and focus on 287 
the need for better treatment outcomes.  288 
 In conclusion, this study demonstrates that concomitant EMD and PJI is a 289 
dreaded combination with poor outcomes regardless of treatment. Eradication of 290 
infection and reconstruction of the extensor mechanism often requires numerous 291 
surgeries and despite great effort ends in failure the majority of the time, usually due to 292 
recurrent infection. Early consideration of fusion or amputation may be preferable to 293 
avoid the morbidity and mortality of repeated surgeries. 294 
  295 
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Figure Legend 
 
Figure 1: Attempted Extensor Mechanism Reconstruction Results 
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Table 1: Factors Associated with Failure Versus Success 
 
 Re-implants & EMR (n=12) Fusion or AKA (n=48) P-Value 
Age 67 years (55-76 years) 66 years (38-83 years) .91 
ASA    
I 0 0 .99* 
II 3 15  
III 5 21  
IV 0 3  
BMI 33 (21-49) 34 (23-49) .80 
 
 
* The p-value was derived using a Fishers Exact Test. ASA was collapsed into two categories by 
combining ASA I and II versus III and IV. 
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EMD/PJI 
(n=60)
Attempted EMR (n=53)
Methods of EMR
* Marlex Mesh (n=8)
* Allograft (n= 14)
* Achilles (n=7)
* Aortobiofem graft (n=10)
* Primary augmention (n=11)
* Other (n=3)
Successful Reimplant + EMR
(n=12, 23%)
Avg # surgeries: 3.5 (range 2-7)
Failures 
(n=41, 77%)
Average # surgeries: 5 (range 1-14)
Failure Modes
* Reinfection 80%
* Failed Extensor Mechanism 20%
Final Surgery
* Fusion (n=26)
* AKA (n=10)
* Chronic Failed Extensor Mechanism (3)
* Chronic Spacer (n=2)
Presentation of EMD/PJI
Successful Replant + EMR Failures
7              Group A EMD -> PJI             20 
3            Group B EMD + PJI                 13 
2              Group A PJI -> EMD              9 
No Attempted EMR
(n=7)
* Early AKA or Fusion
* Fusion (n=6), AKA (n=6)
* Avg # surgeries: 3
